Different DNA damage and cell cycle checkpoint control in low- and high-risk human papillomavirus infections of the vulva (Q44634016)

4 December 2017

title

Different DNA damage and cell cycle checkpoint control in low- and high-risk human papillomavirus infections of the vulva (English)

1 reference

Papillomavirus infections

4 December 2017

main subject

1 reference

Lindy A M Santegoets

1

1 reference

4 December 2017

Romy van Baars

2

1 reference

4 December 2017

Annelinde Terlou

3

1 reference

4 December 2017

Claudia Heijmans-Antonissen

4

1 reference

4 December 2017

Sigrid M A Swagemakers

5

1 reference

4 December 2017

Peter J van der Spek

6

1 reference

4 December 2017

Patricia C Ewing

7

1 reference

4 December 2017

Marc van Beurden

8

1 reference

4 December 2017

Willem I van der Meijden

9

1 reference

4 December 2017

Theo J M Helmerhorst

10

1 reference

4 December 2017

Leen J Blok

11

1 reference

4 December 2017

language of work or name

English

0 references

publication date

30 August 2011

1 reference

International Journal of Cancer

4 December 2017

published in

1 reference

4 December 2017

volume

130

1 reference

4 December 2017

issue

12

1 reference

4 December 2017

page(s)

2874-2885

1 reference

Natural history of cervicovaginal papillomavirus infection in young women.

4 December 2017

cites work

1 reference

Worldwide burden of gynaecological cancer: the size of the problem

21 January 2018

1 reference

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

21 January 2018

1 reference

Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses

21 January 2018

1 reference

Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.

21 January 2018

1 reference

Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999--2004.

21 January 2018

1 reference

Reduced local immunity in HPV-related VIN: expression of chemokines and involvement of immunocompetent cells

21 January 2018

1 reference

Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?

21 January 2018

1 reference

Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities

21 January 2018

1 reference

Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN).

21 January 2018

1 reference

Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia

21 January 2018

1 reference

The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned

21 January 2018

1 reference

Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients

21 January 2018

1 reference

Treatment of vulvar intraepithelial neoplasia with topical imiquimod

21 January 2018

1 reference

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

Loss of estrogen receptor 1 enhances cervical cancer invasion.

21 January 2018

1 reference

Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women

21 January 2018

1 reference

Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling

21 January 2018

1 reference

Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma.

21 January 2018

1 reference

Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers

21 January 2018

1 reference

HPV-16 E7 reveals a link between DNA replication stress, fanconi anemia D2 protein, and alternative lengthening of telomere-associated promyelocytic leukemia bodies

21 January 2018

1 reference

Synchronous multifocal HPV-related neoplasm involving both the genital tract and the head-and-neck area: a case report of Fanconi anemia.

21 January 2018

1 reference

Vulvar squamous cell carcinoma associated with Fanconi's anemia.

21 January 2018

1 reference

Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins

21 January 2018

1 reference

Activation of fanconi anemia pathway in cells with re-replicated DNA.

21 January 2018

1 reference

The human papillomavirus type 16 E7 oncoprotein activates the Fanconi anemia (FA) pathway and causes accelerated chromosomal instability in FA cells

21 January 2018

1 reference

Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture

21 January 2018

1 reference

p53--a Jack of all trades but master of none

21 January 2018

1 reference

Human papillomavirus oncoproteins: pathways to transformation

21 January 2018

1 reference

A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma.

21 January 2018

1 reference

High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva

21 January 2018

1 reference

The cell death machinery governed by the p53 tumor suppressor in response to DNA damage

21 January 2018

1 reference

Association between high risk papillomavirus DNA and nitric oxide release in the human uterine cervix.

21 January 2018

1 reference

Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells.

21 January 2018

1 reference

p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load

21 January 2018

1 reference

Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia

21 January 2018

1 reference

Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin

21 January 2018

1 reference

p16ink4a is a surrogate marker for high-risk and malignant cervical lesions in the presence of human papillomavirus.

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26345

1 reference

4 December 2017

1 reference